MYGN, the Next AMGN

[NY4Ever]

"more than 100,000 deaths and more than 2 million hospitalizations nationwide result annually from medicinal side effects, and that most medicines are developed for the "average" person.
"We don't have all the tests we need to make personalized medicine a reality," he said. "We'll have to make new tests. . . . Best-in-class technology is already available. Myriad has it. Sorenson Genomics has it. We think the key driver for personalized medicine will be the discovery of new content, new markers." From today's Deseret News

[gerihearne]

keep mygn alive

"more than 100,000 deaths and more than 2 million hospitalizations nationwide result annually from medicinal side effects, and that most medicines are developed for the "average" person.
"We don't have all the tests we need to make personalized medicine a reality," he said. "We'll have to make new tests. . . . Best-in-class technology is already available. Myriad has it. Sorenson Genomics has it. We think the key driver for personalized medicine will be the discovery of new content, new markers." From today's Deseret News

ny4ver, are you still accumulating?

[Lyehopper]

I sure there is "goji juice" packed away inside those bundles of straw

Those bundles weren't straw dude.lol

[NY4Ever]

ny4ver, are you still accumulating? >>

I am not adding to my position though I recommend those with no positions or little to at least have enough shares to make it worthwhile being in this stock. Expect MYGN to close its gap shortly and head over 30. Nothing has changed negatively in the fundamentals as time will prove.

[NY4Ever]

Please be advised that I have left the board and will no longer be able to answer any questions you might have regarding MYGN.

[jiesen]

Hi NY,

How do you think the market for chemotherapy drugs such as MYGN is developing will react if a product like this one is successfully developed?

http://www.nanospectra.com/Aurolase.htm

I am seeing a negative trend in the Insulin/Lantus market that is correspoinding to the increased use of the new diabetes therapies introduced by AMLN. I wonder how quickly a breakthrough in cancer treatment would stir things up in that area.

[gerihearne]

ny4ever

Please be advised that I have left the board and will no longer be able to answer any questions you might have regarding MYGN.

Sorry to see you go. All the best to you and your family,
Geri

[Tatnic]

Come on back to aol, that place needs some provacative posters to bring it back from the dead.

[New-born baby]

Mygn

MYGN support failed today, and the fall has begun. Stand back.

[NY4Ever]

MYGN support failed today, and the fall has begun. Stand back.>>

The decline is basically over for MYGN but a lot of damage has been done technically to the stock. I am a buyer. That said, as I posted on another thread last week, April will give back the gains of March. A number of institutions decided to dump their bio-tech stocks this week and the selling began on Monday. Don't fight the interest rate trend.

[New-born baby]

MYGN support failed today, and the fall has begun. Stand back.>>

The decline is basically over for MYGN but a lot of damage has been done technically to the stock. I am a buyer. That said, as I posted on another thread last week, April will give back the gains of March. A number of institutions decided to dump their bio-tech stocks this week and the selling began on Monday. Don't fight the interest rate trend.

NY,
Have you thoughts about where the QQQQs are headed?

[NY4Ever]

NY,
Have you thoughts about where the QQQQs are headed?>>

39.25

[spikefader]

NY,
Have you thoughts about where the QQQQs are headed?>>

39.25

I say 40.25.

[DSteckler]

Next support level for MYGN is a little over 23.

[Tatnic]

Support @ 22.

is my guesstimate.